Dietary regulation of nuclear receptors in obesity-related metabolic syndrome

Asia Pacific Journal of Clinical Nutrition

Volumn 17, Issue SUPPL. 1, 2008, Pages 126-130

  Kawada, Teruo ^a   Goto, Tsuyoshi ^a   Hirai, Shizuka ^a   Kang, Min Sook ^a   Uemura, Taku ^a   Yu, Rina ^b   Takahashi, Nobuyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b University of Ulsan   (South Korea)

Author keywords

Adipocytokine; Metabolic syndrome; Nuclear receptors; Obesity; PPARs

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOSE TISSUE; DRUG POTENTIATION; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; PPAR ALPHA; PPAR GAMMA;

EID: 46049103645     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Bray GA, Bouchard C, James WPT. Definitions and proposed current classification of obesity. Mercel Dekker, Inc. New York. 1998. p.31-40.
2. Shimomura I, Funahashi T, Takahashi M, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med. 1996;2:800-3.
3. Cornelius P, MacDougald A, Lane MD. Regulation of adipocyte development. Ann Rev Nutr. 1994;14: 99-129.
4. Gerhardt CC, Romero IA, Cancello R., Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured humanadipocytes. Mol Cell Endocrinol. 2001;175:81-92.
5. Xu H., Barnes,GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays acrucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-30.
6. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes inadipose tissue. J Clin Invest. 2003; 112:1785-8.
7. Kim CS, Kawada T, Yoo H, Kwon BS, Yu R. Macrophage inflammatory protein-related protein-2, a novel CC chemokine, can regulate preadipocytemigration and adipocyte differentiation. FEBS Lett. 2003;548:125-30.
8. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H. Adiposity elevates plasma MCP-1 levels leading to theincreased CD11b-positive monocytes in mice. J Biol Chem. 2003;278: 46654-60.
9. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesityand insulin resistance. Proc Natl Acad Sci. USA 2003;100:7265-70.
10. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the linkbetween insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4-7.
11. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel, RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
12. Yu R, Kim CS, Kwon BS, Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity. 2006;14:1353-62.
13. Takahashi N, Kawada T, Yamamoto T, Goto T, Taimatsu A, Aoki N, Kawasaki H, Taira K, Yokoyama K, Kamei Y, Fushiki T. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CBP and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor-γ. J Biol Chem. 2002;277:16906-12.
14. Takahashi N, Kawada T, Goto T, Yamamoto T, Taimatsu A, Matsui N, Kimura K, Saitoh M, Hosokawa M, Miyashita K, Fushiki T. Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Letters. 2002;514: 315-22.
15. Kuroyanagi K, Kang M-S, Goto T, Hirai S,Ohyama K, Kusudo T, Yu R, Yano M, Sasaki T, Takahashi N, Kawada T. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2007 Dec 4; [Epub ahead of print]